Patent US5142490A successfully refreshed from Google Patents.
Patent US5753234A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5753234A Expired / Lapsed US ⏱️ 0.0 years remaining

Single-shot vaccine formulation

Assignee: LG Corp
•
Filing: 1996-03-11
•
Granted: 1998-05-19
•
Expires: 2016-03-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A microparticle having a particle size ranging from 0.5 to 300 μm, which is prepared by dissolving an antigen or a mixture of antigens in an aqueous solution, adding a water-soluble substance thereto, and removing water to obtain a core particle and coating the core particle with a biodegradable polymer; and a single-shot vaccine formulation prepared by dispersing the microparticles in an injection medium.

Inventors

  • 👤 Hyeon-Kook Lee
  • 👤 Jung-Hwan Park
  • 👤 Nam-Sok Choi
  • 👤 Myung-Jin Kim
  • 👤 Soo-Hyeon Kim

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 18:24
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5031; A61K39/00; A61K39/12; A61K2039/555; A61K2039/55511; A61K2039/55555; C; C12; C12N; C12N2730/00; C12N2730/00011; C12N2730/10011; C12N2730/10111; C12N2730/10134; Y; Y02; Y02A; Y02A50/00; Y02A50/30

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 50 words
A microparticle having a particle size ranging from 0.5 to 300 μm, which is prepared by dissolving an antigen or a mixture of antigens in an aqueous solution, adding a water-soluble substance thereto, and removing water to obtain a core particle and coating the core particle with a biodegradable polymer.
Claim 2
Dependent Claim 50 words
A microparticle having a particle size ranging from 0.5 to 300 μm, which is prepared by dissolving an antigen or a mixture of antigens in an aqueous solution, adding a water-soluble substance thereto, and removing water to obtain a core particle and coating the core particle with a biodegradable polymer.
Claim 3
Dependent Claim 15 words
The microparticle of claim 1, wherein the antigen is an attenuated, killed or recombinant antigen.
Claim 4
Dependent Claim 17 words
The microparticle of claim 1, wherein the core particle further comprises an adjuvant or an inorganic salt.
Claim 5
Dependent Claim 55 words
The microparticle of claim 1, wherein the antigen is obtained from or directed against the pathogen responsible for one or more of diseases selected from the group consisting of: hepatitis, diphtheria, chickenpox, typhoid, pertussis, tetanus, tuberculosis, salmonellosis, cholera, herpes, yellow fever, measles, poliomyelitis, rubella, mumps, rabies, plaque, schistosomiasis, influenza, trypanosomiasis, leishmaniasis, leprosy, meningitis, and malaria.
Claim 6
Dependent Claim 32 words
The microparticle of claim 3, wherein the adjuvant is alum; muramyl dipeptide, muramyl tripeptide and derivatives thereof; tymosin alpha; monophosphoryl lipid A; saponin; an immunostimulating complex; a polyelectrolyte; or a mixture thereof.
Claim 7
Dependent Claim 25 words
The microparticle of claim 1, wherein the water-soluble substance is used in an amount ranging from 1 to 50 times the weight of the antigen.
Claim 8
Dependent Claim 21 words
The microparticle of claim 1, wherein the water-soluble substance is a saccharide, a protein, an amino acid or a mixture thereof.
Claim 9
Dependent Claim 29 words
The microparticle of claim 7, wherein the saccharide is a cellulosic polymer, glucose, xylose, galactose, fructose, lactose, maltose, saccharose, alginate, dextran, hyaluronic acid, chondroitin sulfate or a mixture thereof.
Claim 10
Dependent Claim 23 words
The microparticle of claim 8, wherein the cellulosic polymer is hydroxypropyl cellulose, hydroxypropylmethyl cellulose, carboxymethyl cellulose, sodium carboxymethyl cellulose or a mixture thereof.
Claim 11
Dependent Claim 15 words
The microparticle of claim 7, wherein the protein is gelatin, albumin or a mixture thereof.
Claim 12
Dependent Claim 23 words
The microparticle of claim 7, wherein the amino acid is glycine, alanine, glutamic acid, arginine, lysine, or a salt or a mixture thereof.
Claim 13
Dependent Claim 19 words
The microparticle of claim 1, wherein the particle size of the core particle ranges from 0.1 to 200 μm.
Claim 14
Dependent Claim 26 words
The microparticle of claim 1, wherein the biodegradable polymer is used in an amount ranging from 1 to 100 times the weight of the core particle.
Claim 15
Dependent Claim 17 words
The microparticle of claim 1, wherein the biodegradable polymer is polyglycolide, polylactide, poly(lactide-co-glycolide) or a mixture thereof.
Claim 16
Dependent Claim 22 words
The microparticle of claim 1, wherein the biodegradable polymer is copolyoxalate, polycaprolactone, poly(lactide-co-caprolactone), polyesteramide, polyorthoester, poly(β-hydroxybutyric acid), polyanhydride or a mixture thereof.
Claim 17
Dependent Claim 21 words
A single-shot vaccine formulation prepared by dispersing microparticles recited in any one of claims 1 to 15 in an injection medium.
Claim 18
Dependent Claim 23 words
The single-shot vaccine formulation of claim 16, wherein the injection medium is a buffer which optionally contains a dispersing agent and/or a preservative.
Claim 19
Dependent Claim 30 words
The single-shot vaccine formulation of claim 17, wherein the injection medium is an edible oil, mineral oil, cod liver oil, squalene, squalane, mono-, di- or triglyceride, or a mixture thereof.
Claim 20
Dependent Claim 31 words
The single-shot vaccine formulation of claim 18, wherein the edible oil is corn oil, sesame oil, olive oil, soybean oil, safflower oil, cotton seed oil, peanut oil or a mixture thereof.

References Cited (Backward Citations)

US4338335A Cited
US4744933A Cited
US5417986A Cited
WO1988007870A1 Cited
US5015476A Cited
US5536508A Cited
US5344644A Cited
WO1994027718A1 Cited
WO1995022318A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-05-18 2001-11-17 2002-05-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-05-18 2005-11-17 2006-05-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-05-18 2009-11-17 2010-05-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag